Attached files
file | filename |
---|---|
8-K - 8-K - NEXGEN BIOFUELS LTD | c13633e8vk.htm |
EXHIBIT 10.1
UTA Capital LLC
100 Executive Drive, Suite 330
West Orange, NJ 07052
100 Executive Drive, Suite 330
West Orange, NJ 07052
Terms for Continued Forbearance and Borrowers Restructuring Plan
This Term Sheet is intended to be a binding obligation of the parties hereto and constitutes a
commitment of Borrower, J. Ram Ajjarapu and Lender to support and implement the restructuring plan
describe herein, subject to further assurances, the Lenders right to request definitive
documentation, and the other terms and conditions provided herein.
Laxai Pharma, Ltd. and OSR Holding Corp. Restructuring Plan
Existing Loan and
Security Documentation:
|
Reference is made to the existing: (i) Note and Warrant Purchase Agreement by and between Laxai Pharma, Ltd., an Israeli company (Borrower or the Company) and UTA Capital LLC, a Delaware limited liability company (Lender or UTA), dated as of March 2, 2010 (the NWPA), as modified by the Loan Extension and Modification Agreement effective as of July 31, 2010 (the Modification Agreement) (ii) Modification Agreement; (iii) Amended And Restated Senior Secured Bridge Note dated as of July 1, 2010 (the Amended Note), (iv) Individual Guaranty of J. Ram Ajjarapu (JRA) executed and delivered as of March 2, 2010 (the PG); (v) Deposit Account Control Agreement dated as of March 15, 2010 among OSR Holding Corp. (the Subsidiary and, with any other subsidiaries or controlled affiliates of the Borrower, the Subsidiaries), Lender and Wachovia Bank, N.A. (the DACA); (vi) Company Pledge and Security Agreement, Subsidiary Guarantee, Pledge and Security Agreement, Shareholder Pledge and Security Agreement, and Membership Interest Pledge and Security Agreement (each of the foregoing as defined in the NWPA and, collectively, with the DACA, being the Collateral Agreements); |
(vi) Ordinary Shares Purchase Warrant for up to 5,800,000 shares
issued March 2, 2010, and the Ordinary Shares Purchase Warrant issued
as of July 1, 2010 for up to 2,020,000 shares (collectively, the
Warrants). |
||
The NWPA, Modification Agreement, Amended Note, PG, DACA and
Collateral Agreements are referred to as the Loan Documents and,
with the Warrants, as the Transaction Documents. This Term Sheet shall constitute an amendment and restatement of each of the Loan Documents, but only to the extent of the terms specified herein. Except as and to the extent modified by this Term Sheet, all terms and conditions of the Loan Documents shall remain in full force and effect. Capitalized terms used herein and not defined herein shall have the meanings ascribed to them in the Transaction Documents. |
||
Lender Forbearance:
|
Lender agrees that, subject to continued performance and compliance
by the Borrower, Subsidiary and JRA with the terms and conditions of
this Term Sheet and of the Transaction Documents as modified hereby,
it will not exercise its remedies under the Loan Documents with
respect to any past breaches by Borrower, Subsidiary or JRA or past
Events of Default which arose prior to the execution and delivery of
this Term Sheet and which were the subject of a notice of default
from the Lender. |
|
Extension of Maturity Date:
|
The new Maturity Date of the Amended Note shall be December 15, 2011
(the Extended Maturity Date). |
|
Principal Amortization:
|
Borrower shall make commercially reasonable best efforts to repay at
least $0.2 million of the outstanding principal balance of the
Amended Note by June 1, 2011. Should Borrower be unable to do so, its
failure to do so shall not be an Event of Default, but Borrower shall
then immediately issue to UTA or its designee a 5-year warrant to
purchase up to 1 million shares of Company common stock at $0.02 per
share, and otherwise having terms comparable to those in the
Warrants. |
|
Events of Default:
|
In addition to the existing Events of Default set forth in the
Amended Note, a breach by the Borrower or any of the Subsidiaries of
the terms and conditions of this Term Sheet shall, if continuing
unremedied for a period of five (5) days after written notice to
Borrower or Subsidiary (as applicable) of such default, constitute an
Event of Default under the Amended Notes and the Collateral
Agreements. |
2
Conversion of Loan Balance:
|
A portion of the principal balance of the Amended Note in the amount
of $240,000 is hereby irrevocably converted into 4,800,000 Ordinary
Shares (the Conversion Shares) at the above-fair market value rate
of $0.05 per share. The Conversion Shares shall be deemed validly
issued and outstanding and entitled to full voting and other legal
rights regardless of the absence of physical certificates, but
Borrower shall promptly cause such physical certificates to be issued
in the name of Lender or its designee. Borrower, Lender and JRA agree
that the fair market value of the Conversion Shares as of the date
hereof is $48,000 ($0.01/share) |
|
Interest Rate:
|
The Interest Rate for the Amended Note effective immediately and
until the Extended Maturity Date shall continue to be 15% per annum,. |
|
Current Loan Balance;
Acknowledgements:
|
The parties agree that after giving effect to prior application of
$100,000 of the LALS Cash AR Security Amount and the conversion of
$240,000 of debt to equity effected by this Term Sheet, the principal
balance of the Amended Note is now $1,100,000. Borrower, JRA and Subsidiary each acknowledge that the Amended Note constitutes a legal, valid, binding and enforceable obligation of the Borrower to UTA that is not subject to any credit, offset, defense, cause of action, setoff, counterclaim or adjustment of any kind, and is secured by the liens and security interests created and granted in or pursuant to the Collateral Agreements, which liens and security interests are legal, valid, binding and enforceable security interests in the Collateral, in each case fully perfected and prior and superior in right to any other person, and that this Term Sheet in no manner impairs or adversely affects such liens and security interests. |
|
Personal Guarantee
Recourse Limited to Bad
Acts:
|
The amount of the Obligations guaranteed by JRA pursuant to the PG
shall hereafter be limited to those arising out of or in connection
with the following: (a) if JRA at any time prior to execution and
delivery of this Term Sheet engaged in acts or omissions, whether as
a director, officer, employee or controlling person, that constituted
(i) fraud or intentional misrepresentation of material facts in
connection with the original loan from UTA, or (ii) fraud,
embezzlement or criminal conduct that resulted in economic or
financial damage to the Borrower or to its ability to repay the
Amended Note (any of the foregoing being Prior Acts or Omissions);
(b) if JRA at any time after execution and delivery of this Term
Sheet |
3
engages in acts or omissions, whether as a director, officer,
employee or controlling person, that constitute (i) fraud or
intentional misrepresentation in connection with the original loan
from UTA or in connection with this Term Sheet, (ii) gross negligence
or willful misconduct, (iii) removal or disposal of any property of
the Borrower or JRA after an Event of Default, (iv) misappropriation,
misapplication or conversion of any proceeds of Borrower or any
Subsidiarys accounts receivable or other collateral or assets of
Borrower or of any of the Subsidiaries, (v) intentional breach of the
Loan Documents, or (vi) criminal conduct; (c) if Schedules A or B
hereto (which Schedules are being exchanged contemporaneously with
execution of this Term Sheet by separately confirmed letter or email)
are not true, correct and complete in all material respects; or (d)
if JRA willfully or in bad faith interferes with, hinders or delays
the exercise of UTAs or the Borrowers rights and remedies under
this Term Sheet (any of the foregoing being Subsequent Acts or
Omissions); provided, however, that JRA shall have no liability
under the PG, as amended hereby, for Prior Acts or Omissions
specifically identified in detail on Schedule C hereto (which
Schedule is being exchanged contemporaneously with execution of this
Term Sheet by separately confirmed letter or email) unless and until
Subsequent Acts or Omissions shall exist or occur. |
||
Transfer of Ordinary
Shares from JRA and
Affiliates
|
JRA and Raca Investors, L.P., a limited partnership (RACA) which is
an affiliate of JRA and a principal shareholder of the Company and
which has previously pledged 31,151,842 ordinary shares of the
Company to UTA as security of the obligations under the Amended Note,
hereby transfer and assign, for no additional consideration, 12
million ordinary shares (the Transferred Shares) of the Company to
UTA or its designees, who shall acquire all right, title and interest
in the Transferred Shares, free of all liens and encumbrances other
than the existing lien and security interest of UTA, except that: |
|
(i) 2 million of the Transferred Shares shall be reconveyed to RACA
when the Companys SEC Report on Form 10-K for the year ended
December 31, 2010 is filed, provided that the filing occurs by April
20, 2011; (ii) 2 million of the Transferred Shares shall be reconveyed to RACA if the Amended Note is repaid in full on or prior to the Extended Maturity Date; and |
4
(iii) of the remaining 8 million Transferred Shares, up to 3 million
shares shall be reconveyed to RACA if the Amended Note is repaid in
full prior to the Extended Maturity Date, with UTA or its designees
becoming indefeasibly vested in those 3 million Transferred Shares
(and RACA no longer having any right to a reconveyance of such
shares) at the rate of 300,000 shares on the 15th of each month
commencing on February 15, 2011 and ending on November 15, 2011. Five (5) million of the Transferred Shares shall not at any time be subject to any contingent rights of reconveyance to RACA. As and when any Transferred Shares are to be reconveyed to RACA, 80% of such otherwise reconveyed Transferred Shares (the Contributed Shares) shall instead be automatically, without further action of RACA, contributed and assigned by RACA, for no additional consideration, to the Company, and shall be held as treasury shares available for issuance or as reserved but unissued shares for any lawful corporate purpose approved by the Companys Board of Directors; provided, however, that such contribution requirement shall terminate when the total number of Contributed Shares equals two (2) million shares. The Transferred Shares shall include all shares beneficially held by JRA, RACA or other affiliates of JRA which are not included in the shares previously pledged by RACA to the Lender. |
||
Company Board of
Directors; Subsidiary
Board of Directors:
|
Effective upon execution of this Term Sheet, the Companys Board of
Directors shall consist of three directors: (i) JRA or his designee,
(ii) E. Thomas Layton (Layton) or another designee of UTA, and
(iii) another individual designated by the holders of a majority of
the ordinary shares purchased for cash by those equity investors who
invested in the Companys private placement prior to March 2, 2010
(the Equity Investor Director). Any member of the Board may call a
meeting of the Board of Directors on five business days prior
written or confirmed email notice to the other directors. The
Chairman shall not have any rights as a director not enjoyed by any
other director. Effective upon execution of this Term Sheet, each Subsidiarys Board of Directors shall consist of three directors: (i) JRA or his designee, (ii) Layton or another designee of UTA, and (iii) the Equity Investor Director. Any member of the Board of a Subsidiary may call a meeting of the Board of Directors of the Subsidiary on five business days prior written or confirmed email notice to the other directors. |
5
Certain Actions Requiring Board Approval: |
The parties hereto agree that approval by vote or written consent of: (a) all of the members of the Board of Directors of the Company and/or Subsidiary, as applicable, shall be required for the: (i) commencement of any litigation by or on behalf of the Company and/or the Subsidiary, whether as direct or derivative action, against UTA, JRA, or any current or former officer or director of the Company or the Subsidiary; and (b) a majority of the Board of Directors of the Company and/or Subsidiary, as applicable, shall be required for the: |
|
(i) filing or other commencement of a federal or state bankruptcy or
insolvency petition or proceeding by or on behalf of Borrower or any
Subsidiary; or (ii) commencement or consummation of any equity or debt financing of the Company or any Subsidiary. The foregoing shall not imply that Board action or approval is not required for any other action or event that under applicable corporate law would normally require Board action or approval. |
||
Certain Financings to Be
Approved:
|
UTA agrees that it shall cause its Board designee to vote for or
consent to (x) any equity financing of the Company that fully repays
all obligations to UTA under the Amended Note, provided it is offered
the opportunity to participate in any such equity financing on a
basis that maintains its beneficial ownership percentage of Company
equity, and (y) any debt financing that fully repays all obligations
to it under the Amended Note. JRA agrees that it shall cause its Board designee to vote for or consent to any debt financing that fully repays all obligations to UTA under the Amended Note. |
|
Voting Agreement:
|
The parties hereto agree to vote any and all shares of the Company
now held or hereafter acquired by them or their family members or
affiliates as follows: (1) for the election and re-election of a Company Board of three directors consisting of (x) Layton or another designee of UTA as a director of the Company, (y) JRA or a designee of JRA as a director, and (z) the Equity Investor Director; (2) for the election and re-election of Layton as Chairman, Chief Executive Officer (CEO) and President and Chief Financial Officer (CFO) of the Company and of each of the Subsidiaries; |
6
(3) for the implementation of cash and asset control and collection
and financial reporting policies and procedures consistent with this
Term Sheet and prevailing business practices for public companies; (4) for approval of the executive compensation matters described below; and (5) for the implementation of the corporate migration described below. This voting agreement shall survive until the first to occur of (i) the Amended Note being repaid in full or (ii) UTA ceasing to have beneficial ownership (calculated in accordance with SEC Rule 13d) of 3 million ordinary shares of the Company. |
||
Company Equity Capital Structure: |
The Companys fully-diluted equity capitalization as of January 15,
2011 is as set forth on Schedule A. All shares of the Subsidiary are
held by the Company, and there are no options, warrants or other
rights to acquire equity of the Subsidiary held by any party other
than the Company. The inclusion in Schedule A of any shares or other
equity instruments as being issued or to be issued is not and should
not be construed as an admission by the Company that any such shares
or equity instruments represent valid and enforceable claims of
equity ownership. |
|
The parties agree to use commercially reasonable best efforts to
terminate or otherwise mitigate the dilutive effect of any obligation
to issue shares or options to Messrs. Maddipatla or Mallakunta or to
any employee or consultant who has been terminated or is terminated
within 30 days after execution and delivery of this Term Sheet
(Excess Equity Grants). The Company, JRA and RACA agree that any Excess Equity Grants, shall, to the extent not terminated by legal action or negotiated settlement within 90 days after execution and delivery of this Term Sheet, be satisfied (x) 25% by JRA transferring 25% of such number of shares (which shall not include Transferred Shares or Contributed Shares but may include shares previously pledged by RACA to UTA to the extent JRA and RACA have no further unpledged shares available) to the grantees of such Excess Equity Grants, and (y) 75% by the Company issuing 75% of the remaining Excess Equity Grants. |
7
Company and Subsidiary
Liabilities:
|
The Companys indebtedness, guarantees, trade accounts payable and
all other Company liabilities as of January 15, 2011 are as set forth
on Schedule B. |
|
The Subsidiarys and each other Subsidiarys indebtedness,
guarantees, trade accounts payable and all other Subsidiary
liabilities as of January 15, 2011 are as set forth on Schedule B. |
||
The inclusion in Schedule B of any amounts as liabilities is not and
should not be construed as an admission by the Company or the
Subsidiary that any amounts represent valid and enforceable claims of
creditors or other third parties. |
||
The parties agree to use commercially reasonable best efforts over
the next 90 days to negotiate, terminate or otherwise mitigate
(including by conversion to equity) the impact of those liabilities
as described on Schedules A/B under the columns UTA agrees and To
be Paid. |
||
Collateral:
|
All collateral which is the subject of the Collateral Agreements
(other than pledged shares included in Transferred Shares, to the
extent such shares are not required to be reconveyed to RACA) shall
be released upon indefeasible repayment of the principal of, and all
accrued interest on, the Amended Note. |
|
Borrower and JRA
Representations and
Warranties:
|
Borrower, Subsidiary and JRA hereby jointly and severally (i)
represent and warrant that the Schedules delivered concurrently
herewith are true and correct, and (ii) acknowledge that the Lender
and Layton are expressly relying on those representations and
warranties and the accuracy of the Schedules as a material basis for
entering into this Term Sheet. A breach of the foregoing
representations and warranties shall constitute an Event of Default. |
|
Changes in Company and OSR
Holding Corp. Officers:
|
Effective immediately, Layton shall be Chairman, CEO and President
and CFO of the Company and of each Subsidiary. JRA hereby resigns from all officer and employee positions with the Company and any of the Subsidiaries. JRA hereby waives any and all claims to unpaid compensation or severance by reason of his past services, and confirms that no family member or affiliate of JRA is entitled to any compensation or reimbursement of expenses from the Company or any of the Subsidiaries. JRA agrees to promptly deliver to Layton all corporate, legal, financial and business records of the Company and each Subsidiary in his possession or under his control, and failure to so deliver any requested records within 5 business days after a written request shall constitute a breach of the Loan Documents and an Event of Default. The officers of the Company shall also be officers of each of the Subsidiaries, with equivalent titles and responsibilities, but with no additional compensation. |
8
Cash and Accounting
Controls:
|
All receipts received from any Subsidiary or Company customers and
clients shall be promptly deposited in the account which is the
subject of the DACA or any successor account (the Lockbox), and all
customers and clients of the Company and of any Subsidiary shall be
directed at all times to direct the payments to the Lockbox. At no time shall any Company or Subsidiary bank or investment accounts be maintained as to which UTA and the Companys designated CFO, Layton, do not have full knowledge and access. Any disbursements from the Lockbox or from the Company/Subsidiary operating account shall require approval of Layton as CFO. Disbursements from the operating account may be made upon the signature or approval of Layton. Layton shall present a rolling six-month operational budget, subject to review and approval by UTA and the Companys Board of Directors. UTA shall approve all disbursements from the Lockbox to pay Company or any Subsidiary expenses which are not in conformity with such previously approved budget. UTA may delegate such approvals to Layton. The parties will cooperate in any process required to replace Wachovia as the Lockbox custodian. Notwithstanding the foregoing, following an Event of Default funds in the Lockbox may be applied in such manner and for such purposes as UTA shall determine. |
|
Officer and Director
Compensation:
|
JRA shall be entitled to receive $5,000 per month (on a 1099 basis)
for a minimum period of 12 months. Such compensation (JRA Variable
Compensation) shall accrue monthly but shall be payable currently
only if in such calendar month the consolidated free cash flow of the
Company and all Subsidiaries after payment of all expenses of
operation (including current interest and reimbursement of Lender
expenses but not amortization of loan principal) but before all
officer and director compensation (Excess Cash Flow), exceeds
$15,000. Any amounts accrued and unpaid shall be deferred and
subordinated to repayment of the Amended Note. |
9
In addition, with respect to each acquisition closed by the Company
within the next 24 months which was originated by JRA, there will be
a finders fee of 5% of the value of the transaction consideration
earned by JRA. |
||
Layton shall be retained as Chairman, CEO and President, and CFO,
with a minimum time commitment of 40 hours per week. In his capacity
as President and CFO, Mr. Layton shall be entitled to receive a
minimum of $8,000 per month (on a 1099 or W-2 basis) (TL Fixed
Compensation). An additional $2,000 per month (TL Variable
Compensation) shall accrue monthly but shall be payable currently
only if in such calendar month the consolidated free cash flow of the
Company and all Subsidiaries after payment of all expenses of
operation (including current interest and reimbursement of Lender
expenses but not amortization of loan principal) but before all
officer and director compensation (Excess Cash Flow), exceeds
$15,000. Any amounts accrued and unpaid shall be deferred and
subordinated to repayment of the Amended Note. |
||
Should Excess Cash Flow for any calendar month exceed $15,000 but be
less than $30,000, JRA and Layton shall each be entitled to receive
their pro rata share (calculated by reference to JRA Variable
Compensation and TL Variable Compensation) of such Excess Cash Flow
after payment of TL Base Compensation. No other director or officer compensation shall be payable by the Company or any Subsidiary prior to repayment of the Amended Note without consent of UTA and the Board of Directors. |
||
Officer and Director
Restrictive Covenants:
|
Each of the directors and officers of the Borrower (including JRA)
hereby agrees that he will not, directly or indirectly, whether
individually or as an officer, director, employee, consultant or 5%
or greater direct or indirect beneficial shareholder, member or
partner of any company or enterprise: (i) solicit business, payments or compensation for CR Services (as defined below) from any individual or entity who is at any time or was since February 1, 2010 a customer or client of any Subsidiary or the Company, whether as a primary direct customer or client or through a secondary or intermediary provider; (i) employ or solicit the employment of (whether as an employee or consultant) any individual or entity who is at any time or was since February 1, 2010 employed or retained as a consultant by the Subsidiary or the Company; or |
10
(iii) compete with any Subsidiary or the Company in the area of
providing clinical research services, whether in the drug discovery
and development area or elsewhere, including biostatistics, data
management, CDISC consulting, medical writing, monitoring,
regulatory, drug safety, and related training programs (collectively,
CR Services). The foregoing restrictive covenants shall terminate upon the first to occur of (i) 24 months from the date of this Term Sheet, or (ii) 12 months after repayment in full of the Amended Note, but as to any individual director or officer no later than 24 months after such individual ceases to provide services to the Company and any Subsidiary, and as to JRA shall terminate if the Company fails to pay JRA his JRA Variable Compensation for any two consecutive or non-consecutive months notwithstanding that the free cash flow condition to such payment has been met for such months. |
||
Other Corporate Assets held by JRA Affiliates: |
JRA shall cause and direct any JRA-affiliated companies holding
personnel, licenses or other tangible or intangible assets, including
H-1B or other visas currently utilized by personnel performing
services for the Company or Subsidiaries, to continue to make such
personnel, visas and other assets available for use by the Company
and its Subsidiaries at no cost or expense, except that the Company
shall reimburse at market rates the direct compensation and benefits
costs actually incurred for those personnel whom the Companys CEO,
President and CFO individually identifies as required personnel and
whom he does not wish to employ directly with the Company or a
Subsidiary. Within 60 days following the execution and delivery of this Term Sheet, the Companys CEO, President and CFO shall identify those H-1B visas which are held by any JRA-affiliated companies which should be transferred to the Borrower or a Subsidiary, and JRA shall cause and direct the applicable JRA-affiliated company to effect such transfers immediately upon request of the Company, at the Companys expense. After such 60-day period, the Company or its Subsidiaries may continue to use visas held by any JRA-affiliated company for employees or agents of the Company or its Subsidiaries, provided that the Company shall reimburse the holder of such visas at market rates for its direct costs actually incurred by such holder in making such visas available. |
11
Use of Name:
|
JRA shall immediately cause each of his direct or indirect affiliates
(other than the Borrower and OSR Holding Corp.) having a legal name
or doing business under a name that includes the words OSR or
Laxai to change their legal name to a name not including such
words, and to refrain, for so long as the Borrower or OSR Holding
Corp. is actively engaged in operations, from using or doing business
under a name or description that includes the words OSR or
Laxai. |
|
Corporate Migration:
|
The parties shall cooperate to cause the Company to migrate its
jurisdiction of organization from Israel to Delaware by June 1, 2011. |
|
Release of JRA, Borrower
and Subsidiary by UTA:
|
UTA, on behalf of itself and each of its affiliates, subsidiaries,
representatives, directors, officers, employees, agents,
administrators, predecessors and successors (collectively, the UTA
Releasing Parties), hereby fully and forever releases, relinquishes,
acquits and discharges the Company, Subsidiary and JRA and each of
their respective affiliates, subsidiaries, prior and existing
stockholders (in their capacities as such), divisions,
representatives, directors, officers, employees, agents,
administrators, predecessors and successors (collectively, the
Company Released Parties), from any and all causes of action,
complaints, contracts, debts, obligations, contributions, liens,
indemnities, promises, demands, damages, losses, attorneys fees,
other fees, costs, expenses, compensation, injuries, liability of any
nature, type or description, or claims of any kind whatsoever,
whether in law or in equity, direct or indirect, based on a contract,
tort, statutory or other theory of recovery or rescission, but only
to the extent specifically disclosed by the Company, Subsidiary or
JRA to UTA and patent and not latent, but whether fixed or
contingent, that any of the UTA Releasing Parties now have or ever
had against any of the Company Released Parties through the date of
this Agreement based on, arising out of, or in any way related to,
UTAs loan to or equity investment in the Company, including, without
limitation, ownership of the Companys securities or actions or
omissions by the Companys Board of Directors or officers (the
Company Released Claims); provided, however, that nothing contained
in this section shall release, relinquish, acquit, discharge or
otherwise affect the representations or obligations of any party
under the Transaction Documents or this Term Sheet. For the sake of
clarity, the Company Released Claims do not include, without
limitation, claims based on a breach of the Transactions Documents
except to the extent specifically identified in detail by the Company
Released Parties on Schedule C hereto (which Schedule is being
exchanged contemporaneously with execution of this Term Sheet by
separately confirmed letter or email), or claims under the PG as
modified by this Term Sheet. |
12
Release of UTA by
Borrower, Subsidiary and
JRA:
|
Each of the Company, the Subsidiary and JRA, on behalf of himself or
itself and each of his or its respective affiliates, subsidiaries,
representatives, directors, officers, employees, agents,
administrators, predecessors and successors (collectively, the
Company Releasing Parties), hereby fully and forever releases,
relinquishes, acquits and discharges UTA and each of its affiliates,
subsidiaries, partners and members (in their capacities as such),
divisions, representatives, directors, officers, employees, agents,
administrators, predecessors and successors (collectively, the UTA
Released Parties), from any and all causes of action, complaints,
contracts, debts, obligations, contributions, liens, indemnities,
promises, demands, damages, losses, attorneys fees, other fees,
costs, expenses, compensation, injuries or liability of any nature,
type or description, or claims of any kind whatsoever, whether in law
or in equity, direct or indirect, based on a contract, tort,
statutory or other theory of recovery or rescission, known or
unknown, suspected or unsuspected, patent or latent, fixed or
contingent that the Company Releasing Parties now have or ever had
against the UTA Released Parties through the date of this Agreement
based on, arising out of or in any way related to, the Company, the
Subsidiary, the UTA investment in the Company, the administration or
funding thereof or the Transaction Documents (the UTA Released
Claims); provided, however, that nothing contained in this section
shall release, relinquish, acquit, discharge or otherwise affect the
representations or obligations of any party under this Term Sheet.
For the sake of clarity, the UTA Released Claims include, without
limitation, claims based on the Transaction Documents or based on
alleged usury or lender liability, including but not limited to
claims alleging breach of the Transaction Documents, fraud,
interference with Borrowers contractual relationships, negligence,
breach of covenant of good faith and fair dealing, breach of
fiduciary duty, violations of federal anti-racketeering statutes,
control of the Borrower, economic duress or prima facie tort. |
|
Dismissal of Litigation:
|
Concurrently with execution and delivery of this Term Sheet, (a) the
Borrower and Subsidiary are causing the Florida complaint filed in
December 2010 against UTA to be dismissed, with prejudice, and (b)
UTA is causing the New York State motion for summary judgment in lieu
of complaint action commenced in January 2011 against JRA to be
dismissed, but without prejudice. UTA covenants that it will not
re-commence an action against JRA on the PG unless based on the terms
of the PG as amended and modified as described above under Personal
Guarantee Recourse Limited to Bad Acts.. |
13
Reimbursement of Lender,
Borrower and JRA Expenses:
|
Borrower shall pay to Lender all of Lenders legal and other fees
previously incurred relating to prior refinancing efforts or
otherwise incurred in negotiation and documentation of this Term
Sheet and the restructuring contemplated hereby. A minimum of $5,000
of such expenses shall be reimbursed upon execution and delivery of
this Term Sheet, and the balance in six equal monthly installments,
provided that the first monthly installment shall be no less than the
Borrower legal expense payment made one month after execution and
delivery of this Term Sheet, as described below. The Borrower shall
pay (or reimburse JRA for) his legal expenses in negotiating this
Term Sheet up to $2,500, payable within 10 days of the signing of
this Term Sheet upon receipt of invoices from counsel for such
services. Borrower shall, as a mandatory element of the initial six-month budget, pay (or reimburse JRA for, to the extent he can document that he advanced funds for payment of) its legal expenses incurred in negotiation and documentation of this Term Sheet and the restructuring contemplated hereby. A minimum of $5,000 of such expenses shall be paid or reimbursed upon execution and delivery of this Term Sheet, and the balance (not to exceed $5,000) one month later, each upon receipt of invoices from counsel for such services. |
|
Cancellation and
Termination of Invalid
Company Agreements:
|
The new CEO, President and CFO shall conduct a review of all prior
Company and Subsidiary agreements. Any prior agreements entered into
with parties other than UTA that were not, based on the review of
corporate counsel, approved in accordance with applicable corporate
law will be cancelled and terminated by the Company (or by the
applicable Subsidiary) if such action is in the best interests of the
Company and its creditors and equity holders. The purchase and sale
of OSR Solutions, Inc. and OSR Enterprises, LLC from NexGen Biofuels,
Inc. pursuant to agreements entered into as of December 1, 2010 shall
not be subject to the foregoing cancellation and termination process
unless a majority of the Board of Directors reasonably determines
(without regard to the affiliated party aspects of such transactions)
that such transactions, taken as a whole, either (x) conferred no
material benefit on the Borrower or (y) resulted in the assumption of
liabilities substantially disproportionate to the benefits to the
Borrower. |
14
Indemnification:
|
Borrower, Subsidiary and JRA will hold Lender harmless from any and
all damages or liabilities arising in connection with this
restructuring other than as a result of Lenders fraud or willful
misconduct. Borrower and Subsidiary hereby confirm that JRA is and shall remain entitled to such statutory rights to indemnification by Borrower or Subsidiary as may be available to him under applicable Israeli or Delaware law or as may be available to him by the provisions of their respective articles of association, certificate of incorporation and/or bylaws as currently in effect. |
|
Enforcement:
|
The following terms are an essential and material inducement for the
Lenders forbearance under this Term Sheet and agreement to the
restructuring contemplated hereby. |
|
Borrower, the Subsidiary and JRA acknowledge that their respective
strict compliance with the terms of this Term Sheet is an essential
and material element of consideration in UTAs decision to exercise
forbearance and to extend the Maturity Date of the Amended Note. Borrower, Subsidiary and JRA each acknowledges that any breach of any of the provisions of this Agreement will result in serious and irreparable injury to UTA for which UTA cannot be adequately compensated by monetary damages alone. Each of Borrower, Subsidiary and JRA agrees, therefore, that, in addition to any other remedy that UTA may have, UTA shall be entitled to enforce the specific performance of this Term sheet and the Transaction Documents by any of the parties and to seek both temporary and permanent injunctive relief without the necessity of proving actual damages or posting a bond. Such remedies shall not be deemed to be the exclusive remedies for a breach by any of the parties of any of the provisions of this Agreement but shall be in addition to all other remedies available at law or equity to UTA. In addition to, and not in lieu of, UTAs existing remedies under the PG and the other Loan Documents following an Event of Default and the remedy of specific performance, JRA agrees that upon an Event of Default, any and all JRAs rights (a) in and to the Transferred Shares, (b) to vote the Pledged Shares, (c) to serve as or receive compensation as a consultant of the Company or the Subsidiary, and/or (d) to require other parties hereto to vote for his designee as a director of the Company, shall automatically terminate and be null and void, without further action by JRA. |
15
As a further inducement to Lender to agree to this restructuring,
each of Borrower, Subsidiary and JRA hereby waives, to the maximum
extent possible under law, any right to challenge UTAs exercise of
its remedies under the Loan Documents and this Term Sheet, whether
such right or challenge might be asserted in an action in law, in
equity or in connection with any bankruptcy proceeding of the
Borrower, Subsidiary and/or JRA. |
||
Expiration Date:
|
This Term Sheet shall expire if not accepted and agreed by the
Borrower, Subsidiary, RACA and JRA on or before February 18, 2011. |
|
Further Assurances; More
Definitive Documentation:
|
Lender shall have the right to determine in its sole discretion, that
additional more definitive documentation is required to properly
protect its rights. Such documentation shall be reasonably
satisfactory to Lender, Lenders counsel, Borrower, and Borrowers
counsel. The documents are to be prepared by Lenders counsel and
reviewed by Borrowers counsel. If the parties have not entered into such requested definitive documents consistent with this Term Sheet and otherwise reasonably satisfactory to the Lender within 20 business days of Lender communicating such determination to the Borrower, Lender may declare an Event of Default. The parties hereto agree that this Term Sheet is a Binding Agreement as defined in the Letter Agreement dated as of December 10, 2010 among the parties hereto (the Pre-Negotiation Agreement), and that the Pre-Negotiation Agreement is hereby terminated, effective as of February 11, 2011. |
|
Governing Law and Venue:
|
This Term Sheet, the Loan Documents and any more definitive
transaction documents will be governed by the laws of the State of
New Jersey, without regard to the principles of conflict of laws
thereof. The United States District Court for the Southern District
of New York and the New York State courts in New York County shall be
the exclusive venue for the adjudication of all disputes among the
parties, except that Borrower and Subsidiary agree that any future
Chapter 11 filing by either of the Borrower or Subsidiary that is
filed while the Amended Note is outstanding or within 12 months
following repayment of the Amended Note may be filed only in the
State of Texas or the State of New Jersey, where the Borrower and
Subsidiary maintain or intend to maintain material ongoing business
operations. The foregoing provisions are intended to, and shall
replace, any alternative or conflicting choice of law or jurisdiction
provisions set forth in the Loan Documents. |
16
Matters Relating to
Chapter 11 Petitions:
|
Each of the Borrower, OSR Holding Corp., Lender and JRA agree to use
their best efforts to cause the recently filed Chapter 11 petitions
with respect to the Company and OSR Holding Corp. to be immediately
withdrawn or dismissed, with no conditions attached to such
withdrawal or dismissal, and the assets, operations and business of
the Borrower and OSR Holding Corp. no longer subject to the
jurisdiction of the Bankruptcy Court. Each of the parties hereto
agrees not to seek sanctions or other disciplinary relief with
respect to the filing of such Chapter 11 petitions. To the extent the prompt withdrawal or dismissal of the Chapter 11 cases requires approval by the Bankruptcy Court of any partys entry into this Term Sheet as a condition of its binding nature and effectiveness, all parties hereto agree to use their best efforts to seek such approval on an expedited basis. If the enforceability of this Term Sheet as against any party hereto requires such Bankruptcy Court approval, all other parties shall nonetheless remain bound hereby while such approval is being sought and obtained, unless such approval, despite best efforts, is not obtained within 15 business days of the execution of this Term Sheet. |
The parties hereto agree to negotiate in good faith, using commercially reasonable efforts,
more definitive documents for the restructuring transactions described herein if and when such
additional definitive documentation is determined by Lender to be required or appropriate.
Please indicate your acknowledgment of the foregoing by returning to us a signed copy of this Term
Sheet.
[Signature Page Follows]
17
Agreed and accepted February 18th, 2011
UTA CAPITAL LLC |
||||
By: | YZT MANAGEMENT LLC, its Managing Member |
By: | /s/ Udi Toledano | ||||
Name: | Udi Toledano | ||||
Title: | Managing Member |
LAXAI PHARMA, LTD. |
||||
By: | /s/ J. Ram Ajjarapu | |||
Name: | J. Ram Ajjarapu | |||
Title: | Executive Chairman | |||
OSR HOLDING CORP. |
||||
By: | /s/ E. Thomas Layton | |||
Name: | E. Thomas Layton | |||
Title: | Chairman of the Board and CEO | |||
/s/ J. Ram Ajjarapu | ||||
J. Ram Ajjarapu | ||||
RACA INVESTORS, L.P. | ||||
By: | /s/ Aruma Raj Ajjarapu | |||
Name: | Aruma Raj Ajjarapu | |||
Title: | Managing Partner | |||
INTERNATIONAL CAPITAL PARTNERS, LLC |
||||
By: | /s/ Aruma Raj Ajjarapu | |||
Name: | Aruma Raj Ajjarapu | |||
Title: | Managing Member | |||
/s/ E. Thomas Layton | ||||
E. Thomas Layton (signatory only as to the matters | ||||
described under Cash and Accounting Controls, Director and Officer Compensation, and Officer and Director Restrictive Covenants) |
18